Skip to main content
Log in

Bendamustine/rituximab

Epstein-Barr virus associated lymphoproliferative disorder: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Muroi K, et al. Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab. Annals of Hematology 94: 2061-2062, No. 12, 4 Aug 2015 - Japan

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bendamustine/rituximab. Reactions Weekly 1576, 57 (2015). https://doi.org/10.1007/s40278-015-10213-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-10213-z

Navigation